Cannabidiol research
Search documents
CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD
Accessnewswire· 2025-12-23 00:00
Core Viewpoint - CV Sciences, Inc. supports President Trump's Executive Order aimed at enhancing cannabidiol research to better inform patients and doctors [1] Group 1: Company Overview - CV Sciences, Inc. is a leading consumer wellness company that specializes in hemp extracts and other scientifically-backed natural ingredients and products [1] Group 2: Industry Impact - The Executive Order directs agencies within the Department of Health and Human Services to facilitate access to full-spectrum CBD products for Americans based on research methods utilizing real-world evidence [1]